NCT06513884 2025-06-22A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal CancerHookipa Biotech GmbHPhase 2/3 Withdrawn
NCT04129320 2022-02-08Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and NeckMacroGenicsPhase 2/3 Withdrawn